Skip to content

A randomized controlled clinical study on the efficacy evaluation of acupuncture treatment for chronic atrophic gastritis

A randomized controlled clinical study on the efficacy evaluation of acupuncture treatment for chronic atrophic gastritis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071988
Enrollment
Unknown
Registered
2023-05-31
Start date
2023-06-02
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic atrophic gastritis

Interventions

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria of Western medicine for chronic atrophic gastritis, at least one type of syndrome differentiation in traditional Chinese medicine; (2) Individuals aged 18 years <= 75 years old, regardless of gender; (3) Can cooperate with treatment, relevant examinations and evaluations; (4) Sign an informed consent form and voluntarily participate in this study; Note: Patients who meet all four criteria must be included in this study.

Exclusion criteria

Exclusion criteria: (1) Unable to cooperate with researchers due to severe mental illness, such as schizophrenia, depression, anxiety, etc; (2) Having undergone stomach surgery or undergoing major surgery that resulted in important organ deficiencies, changes, or obvious scarring along the meridian, or those with disabilities; (3) Suspected malignant transformation or gastrointestinal tumor in gastrointestinal mucosal lesions; (4) Combined autoimmune gastritis (type A chronic atrophic gastritis), peptic ulcer, esophageal hiatus, diseases such as hernia, hypertrophic gastritis, ulcerative colitis, etc; (5) Individuals with severe primary diseases such as cardiovascular, liver, kidney, digestive, hematopoietic, and immune systems; (6) Pregnant and lactating women; (7) Participants in other ongoing clinical studies; Note: Patients who meet any of the above criteria will be excluded.

Design outcomes

Primary

MeasureTime frame
Acupuncture response rate;Gastrointestinal Symptom Rating Scale;

Secondary

MeasureTime frame
Quality of life score;Psychological assessment;Gastric mucosal pathological tissue score;Adverse event;

Countries

China

Contacts

Public ContactYing Li

Chengdu University of Traditional Chinese Medicine

liying@cdutcm.edu.cn+86 137 0809 5607

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026